CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in awareness and adoption of combination medication
3.4.1.2. Rise in incidences of bacterial infections
3.4.1.3. Availability of generic medications
3.4.2. Restraints
3.4.2.1. Side effects associated with penicillin
3.4.2.2. Increase in Resistance to Anti-microbials
3.4.3. Opportunities
3.4.3.1. Rise in investments in R&D activities
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PENICILLIN DRUG MARKET, BY SOURCE
4.1. Overview
4.1.1. Market size and forecast
4.2. Natural penicillin
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Semisynthetic penicillin
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Semisynthetic penicillin Penicillin Drug Market by Class
CHAPTER 5: PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oral
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Parenteral
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY
6.1. Overview
6.1.1. Market size and forecast
6.2. Narrow spectrum penicillin
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Broad spectrum penicillin
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Extended spectrum penicillin
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospital Pharmacies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Drug Stores and Retail Pharmacies
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Online Providers
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: PENICILLIN DRUG MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Source
8.2.3. Market size and forecast, by Route of Administration
8.2.4. Market size and forecast, by Spectrum of Activity
8.2.5. Market size and forecast, by Distribution Channel
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Source
8.2.6.1.3. Market size and forecast, by Route of Administration
8.2.6.1.4. Market size and forecast, by Spectrum of Activity
8.2.6.1.5. Market size and forecast, by Distribution Channel
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Source
8.2.6.2.3. Market size and forecast, by Route of Administration
8.2.6.2.4. Market size and forecast, by Spectrum of Activity
8.2.6.2.5. Market size and forecast, by Distribution Channel
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Source
8.2.6.3.3. Market size and forecast, by Route of Administration
8.2.6.3.4. Market size and forecast, by Spectrum of Activity
8.2.6.3.5. Market size and forecast, by Distribution Channel
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Source
8.3.3. Market size and forecast, by Route of Administration
8.3.4. Market size and forecast, by Spectrum of Activity
8.3.5. Market size and forecast, by Distribution Channel
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Source
8.3.6.1.3. Market size and forecast, by Route of Administration
8.3.6.1.4. Market size and forecast, by Spectrum of Activity
8.3.6.1.5. Market size and forecast, by Distribution Channel
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Source
8.3.6.2.3. Market size and forecast, by Route of Administration
8.3.6.2.4. Market size and forecast, by Spectrum of Activity
8.3.6.2.5. Market size and forecast, by Distribution Channel
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Source
8.3.6.3.3. Market size and forecast, by Route of Administration
8.3.6.3.4. Market size and forecast, by Spectrum of Activity
8.3.6.3.5. Market size and forecast, by Distribution Channel
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Source
8.3.6.4.3. Market size and forecast, by Route of Administration
8.3.6.4.4. Market size and forecast, by Spectrum of Activity
8.3.6.4.5. Market size and forecast, by Distribution Channel
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Source
8.3.6.5.3. Market size and forecast, by Route of Administration
8.3.6.5.4. Market size and forecast, by Spectrum of Activity
8.3.6.5.5. Market size and forecast, by Distribution Channel
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Source
8.3.6.6.3. Market size and forecast, by Route of Administration
8.3.6.6.4. Market size and forecast, by Spectrum of Activity
8.3.6.6.5. Market size and forecast, by Distribution Channel
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Source
8.4.3. Market size and forecast, by Route of Administration
8.4.4. Market size and forecast, by Spectrum of Activity
8.4.5. Market size and forecast, by Distribution Channel
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Source
8.4.6.1.3. Market size and forecast, by Route of Administration
8.4.6.1.4. Market size and forecast, by Spectrum of Activity
8.4.6.1.5. Market size and forecast, by Distribution Channel
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Source
8.4.6.2.3. Market size and forecast, by Route of Administration
8.4.6.2.4. Market size and forecast, by Spectrum of Activity
8.4.6.2.5. Market size and forecast, by Distribution Channel
8.4.6.3. India
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Source
8.4.6.3.3. Market size and forecast, by Route of Administration
8.4.6.3.4. Market size and forecast, by Spectrum of Activity
8.4.6.3.5. Market size and forecast, by Distribution Channel
8.4.6.4. Australia
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Source
8.4.6.4.3. Market size and forecast, by Route of Administration
8.4.6.4.4. Market size and forecast, by Spectrum of Activity
8.4.6.4.5. Market size and forecast, by Distribution Channel
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Source
8.4.6.5.3. Market size and forecast, by Route of Administration
8.4.6.5.4. Market size and forecast, by Spectrum of Activity
8.4.6.5.5. Market size and forecast, by Distribution Channel
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Source
8.4.6.6.3. Market size and forecast, by Route of Administration
8.4.6.6.4. Market size and forecast, by Spectrum of Activity
8.4.6.6.5. Market size and forecast, by Distribution Channel
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Source
8.5.3. Market size and forecast, by Route of Administration
8.5.4. Market size and forecast, by Spectrum of Activity
8.5.5. Market size and forecast, by Distribution Channel
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Source
8.5.6.1.3. Market size and forecast, by Route of Administration
8.5.6.1.4. Market size and forecast, by Spectrum of Activity
8.5.6.1.5. Market size and forecast, by Distribution Channel
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Source
8.5.6.2.3. Market size and forecast, by Route of Administration
8.5.6.2.4. Market size and forecast, by Spectrum of Activity
8.5.6.2.5. Market size and forecast, by Distribution Channel
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Source
8.5.6.3.3. Market size and forecast, by Route of Administration
8.5.6.3.4. Market size and forecast, by Spectrum of Activity
8.5.6.3.5. Market size and forecast, by Distribution Channel
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Source
8.5.6.4.3. Market size and forecast, by Route of Administration
8.5.6.4.4. Market size and forecast, by Spectrum of Activity
8.5.6.4.5. Market size and forecast, by Distribution Channel
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. GlaxoSmithKline plc
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. Pfizer Inc.
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Novartis AG
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Lupin
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. Abbott Laboratories
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. Cipla Ltd
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. Takeda Pharmaceutical Company Ltd
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.8. Alkem Laboratories Ltd.
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.9. Teva Pharmaceutical Industries Limited
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.10. SUN PHARMACEUTICAL INDUSTRIES LIMITED
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
TABLE 01. GLOBAL PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 02. PENICILLIN DRUG MARKET FOR NATURAL PENICILLIN, BY REGION, 2022-2032 ($MILLION)
TABLE 03. PENICILLIN DRUG MARKET FOR SEMISYNTHETIC PENICILLIN, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL SEMISYNTHETIC PENICILLIN PENICILLIN DRUG MARKET, BY CLASS, 2022-2032 ($MILLION)
TABLE 05. GLOBAL PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 06. PENICILLIN DRUG MARKET FOR ORAL, BY REGION, 2022-2032 ($MILLION)
TABLE 07. PENICILLIN DRUG MARKET FOR PARENTERAL, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 09. PENICILLIN DRUG MARKET FOR NARROW SPECTRUM PENICILLIN, BY REGION, 2022-2032 ($MILLION)
TABLE 10. PENICILLIN DRUG MARKET FOR BROAD SPECTRUM PENICILLIN, BY REGION, 2022-2032 ($MILLION)
TABLE 11. PENICILLIN DRUG MARKET FOR EXTENDED SPECTRUM PENICILLIN, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 13. PENICILLIN DRUG MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
TABLE 14. PENICILLIN DRUG MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
TABLE 15. PENICILLIN DRUG MARKET FOR ONLINE PROVIDERS, BY REGION, 2022-2032 ($MILLION)
TABLE 16. PENICILLIN DRUG MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 21. NORTH AMERICA PENICILLIN DRUG MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 22. U.S. PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 23. U.S. PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 24. U.S. PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 25. U.S. PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 26. CANADA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 27. CANADA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 28. CANADA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 29. CANADA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 30. MEXICO PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 31. MEXICO PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 32. MEXICO PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 33. MEXICO PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 34. EUROPE PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 35. EUROPE PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 36. EUROPE PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 37. EUROPE PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 38. EUROPE PENICILLIN DRUG MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 39. GERMANY PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 40. GERMANY PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 41. GERMANY PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 42. GERMANY PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 43. FRANCE PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 44. FRANCE PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 45. FRANCE PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 46. FRANCE PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 47. UK PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 48. UK PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 49. UK PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 50. UK PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 51. ITALY PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 52. ITALY PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 53. ITALY PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 54. ITALY PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 55. SPAIN PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 56. SPAIN PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 57. SPAIN PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 58. SPAIN PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 59. REST OF EUROPE PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 60. REST OF EUROPE PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 61. REST OF EUROPE PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 62. REST OF EUROPE PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 63. ASIA-PACIFIC PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 64. ASIA-PACIFIC PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 65. ASIA-PACIFIC PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 66. ASIA-PACIFIC PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 67. ASIA-PACIFIC PENICILLIN DRUG MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 68. JAPAN PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 69. JAPAN PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 70. JAPAN PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 71. JAPAN PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 72. CHINA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 73. CHINA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 74. CHINA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 75. CHINA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 76. INDIA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 77. INDIA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 78. INDIA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 79. INDIA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 80. AUSTRALIA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 81. AUSTRALIA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 82. AUSTRALIA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 83. AUSTRALIA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 84. SOUTH KOREA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 85. SOUTH KOREA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 86. SOUTH KOREA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 87. SOUTH KOREA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 92. LAMEA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 93. LAMEA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 94. LAMEA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 95. LAMEA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 96. LAMEA PENICILLIN DRUG MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 97. BRAZIL PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 98. BRAZIL PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 99. BRAZIL PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 100. BRAZIL PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 101. SAUDI ARABIA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 102. SAUDI ARABIA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 103. SAUDI ARABIA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 104. SAUDI ARABIA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 105. SOUTH AFRICA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 106. SOUTH AFRICA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 107. SOUTH AFRICA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 108. SOUTH AFRICA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 109. REST OF LAMEA PENICILLIN DRUG MARKET, BY SOURCE, 2022-2032 ($MILLION)
TABLE 110. REST OF LAMEA PENICILLIN DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 111. REST OF LAMEA PENICILLIN DRUG MARKET, BY SPECTRUM OF ACTIVITY, 2022-2032 ($MILLION)
TABLE 112. REST OF LAMEA PENICILLIN DRUG MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 113. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
TABLE 114. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 115. GLAXOSMITHKLINE PLC: PRODUCT SEGMENTS
TABLE 116. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 117. GLAXOSMITHKLINE PLC: KEY STRATERGIES
TABLE 118. PFIZER INC.: KEY EXECUTIVES
TABLE 119. PFIZER INC.: COMPANY SNAPSHOT
TABLE 120. PFIZER INC.: PRODUCT SEGMENTS
TABLE 121. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 122. NOVARTIS AG: KEY EXECUTIVES
TABLE 123. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 124. NOVARTIS AG: PRODUCT SEGMENTS
TABLE 125. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 126. NOVARTIS AG: KEY STRATERGIES
TABLE 127. LUPIN: KEY EXECUTIVES
TABLE 128. LUPIN: COMPANY SNAPSHOT
TABLE 129. LUPIN: PRODUCT SEGMENTS
TABLE 130. LUPIN: PRODUCT PORTFOLIO
TABLE 131. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 132. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 133. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 134. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 135. CIPLA LTD: KEY EXECUTIVES
TABLE 136. CIPLA LTD: COMPANY SNAPSHOT
TABLE 137. CIPLA LTD: PRODUCT SEGMENTS
TABLE 138. CIPLA LTD: PRODUCT PORTFOLIO
TABLE 139. TAKEDA PHARMACEUTICAL COMPANY LTD: KEY EXECUTIVES
TABLE 140. TAKEDA PHARMACEUTICAL COMPANY LTD: COMPANY SNAPSHOT
TABLE 141. TAKEDA PHARMACEUTICAL COMPANY LTD: PRODUCT SEGMENTS
TABLE 142. TAKEDA PHARMACEUTICAL COMPANY LTD: PRODUCT PORTFOLIO
TABLE 143. ALKEM LABORATORIES LTD.: KEY EXECUTIVES
TABLE 144. ALKEM LABORATORIES LTD.: COMPANY SNAPSHOT
TABLE 145. ALKEM LABORATORIES LTD.: PRODUCT SEGMENTS
TABLE 146. ALKEM LABORATORIES LTD.: PRODUCT PORTFOLIO
TABLE 147. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: KEY EXECUTIVES
TABLE 148. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT
TABLE 149. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT SEGMENTS
TABLE 150. TEVA PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO
TABLE 151. SUN PHARMACEUTICAL INDUSTRIES LIMITED: KEY EXECUTIVES
TABLE 152. SUN PHARMACEUTICAL INDUSTRIES LIMITED: COMPANY SNAPSHOT
TABLE 153. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT SEGMENTS
TABLE 154. SUN PHARMACEUTICAL INDUSTRIES LIMITED: PRODUCT PORTFOLIO
